{
    "Trade/Device Name(s)": [
        "Total Bilirubin (T BIL)"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K152344",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063845"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFM"
    ],
    "Summary Letter Date": "December 15, 2015",
    "Summary Letter Received Date": "December 17, 2015",
    "Submission Date": "December 7, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1110"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total or direct) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Bilirubin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "RX Daytona plus analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Vanadate oxidation method",
        "Endpoint spectrophotometric measurement"
    ],
    "Methodologies": [
        "Spectrophotometry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Total Bilirubin assay kit using vanadate oxidation on RX Daytona plus analyzer for quantitative measurement in serum and plasma",
    "Indications for Use Summary": "For quantitative in vitro determination of Total Bilirubin in serum and plasma; used in diagnosis and treatment of hemolytic, biliary, and liver disorders, including hepatitis and cirrhosis",
    "fda_folder": "Clinical Chemistry"
}